Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Joshua Meyer

Center AffiliationsMolecular Therapeutics

Publications (72) (print view)

no pagination
Smaglo BG, Tesfaye A, Halfdanarson TR, Meyer JE, Wang J, Gatalica Z, Reddy S, Arguello D, Boland PM. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. Oncotarget. 2015 Dec 22;6(41):43594-604.   PMCID: PMC4791253
Veltchev I, Fourkal E, Doss M, Yu J, Meyer J, Ma C. SU-F-BRA-15: Physical Aspects and Clinical Applications of Post-Treatment Yttrium-90 PET-Based Dosimetry. Med Phys. 2015 Jun;42(6):3537.
Wang LS, Shaikh T, Handorf EA, Hoffman JP, Cohen SJ, Meyer JE. Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Practical radiation oncology. 2015 Sep;5(5):e457-63.   PMCID: 4814166
Chen KT, Devarajan K, Milestone BN, Cooper HS, Denlinger C, Cohen SJ, Meyer JE, Hoffman JP. Neoadjuvant Chemoradiation and Duration of Chemotherapy Before Surgical Resection for Pancreatic Cancer: Does Time Interval Between Radiotherapy and Surgery Matter?. Annals of Surgical Oncology. 2014 Feb;21(2):662-9.
Cohen SJ, Konski AA, Putnam S, Ball DS, Meyer JE, Yu JQ, Astsaturov I, Marlow C, Dickens A, Cade DN, Meropol NJ. Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer. Br J Cancer. 2014 Jul 15;111(2):265-71.   PMCID: Pmc4102951
Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, Kuten A, Meyer JE, LeBlang SD, Roberts A, Choi J, Larner JM, Napoli A, Turkevich VG, Inbar Y, Tempany CM, Pfeffer RM. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. Journal of the National Cancer Institute. 2014 May;106(5).   PMCID: 4112926
Konski A, Meyer JE, Joiner M, Hall MJ, Philip P, Shields A, McSpadden E, Choi M, Adaire B, Duncan G, Meropol NJ, Cescon TP, Cohen SJ. Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer. Radiother Oncol. 2014 Oct;113(1):35-40.
Papavasiliou P, Hoffman JP, Cohen SJ, Meyer JE, Watson JC, Chun YS. Impact of preoperative therapy on patterns of recurrence in pancreatic cancer. Hpb. 2014 Jan;16(1):34-9.   PMCID: PMC 3892312
Fourkal E, Veltchev I, Lin M, Koren S, Meyer J, Doss M, Yu JQ. 3D inpatient dose reconstruction from the PET-CT imaging of (90)Y microspheres for metastatic cancer to the liver: Feasibility study. Med Phys. 2013 Aug;40(8):081702.
Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer. J Gastrointest Cancer. 2013 Dec;44(4):450-5.   PMCID: Pmc3963822
Tait LM, Meyer JE, McSpadden E, Cheng JD, Baciewicz FA, Meropol NJ, Cohen SJ, Wozniak AJ, Choi M, Konski AA. Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma. Practical radiation oncology. 2013 Oct;3(4):e149-55.   PMCID: No NIH funds
Meyer JS, Alvarez C, Milikowski C, Olson N, Russo I, Russo J, Glass A, Zehnbauer BA, Lister K, Parwaresch RG. Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Modern Pathology. 2005 Aug;18(8):1067-78.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Joshua Meyer Sparkline Graph

Graph Interactions


Similar Investigators:

Keywords (MeSH):

Last updated on Sunday, July 12, 2020